BLOG: 5 things you should know about sleep and concussions

December 20, 2019
by Michael S. Jaffee, MD, FAAN, FANA You might not think about sleep as being related to concussions, but there are a number of ways that a good…

Aldeyra begins phase 3 proliferative vitreoretinopathy prevention trial

December 20, 2019
Aldeyra has enrolled the first patient in a phase 3 clinical trial of ADX-2191 for the prevention of recurrent retinal detachment due to…

Retinitis pigmentosa stem cell therapy trial tops 2019 retina news

December 19, 2019
The top retina-related stories on in 2019 included trial results, meeting coverage and FDA approvals. Here are the top five most-read…

Meeting News

Increase in myopia will lead to rise in retinal conditions

December 19, 2019
ORLANDO, Fla. – The growing incidence of myopia will be associated with an increased risk of retinal conditions, and patients should be…

In the JournalsPerspective

Eyes experience thinning of ganglion cell-inner plexiform layer after epiretinal membrane surgery

December 18, 2019
Eyes that underwent epiretinal membrane surgery experienced progressive thinning of the ganglion cell-inner plexiform layer and worsening Humphrey…

Patient-derived stem cell therapy trial for geographic atrophy launches

December 17, 2019
A clinical trial testing the safety of a patient-specific stem cell-based therapy for the treatment of geographic atrophy has been launched by the…

What's Your Diagnosis?

Routine eye exam reveals distinctive macular lesion

Primary Care Optometry News, December 2019
Mary G. Hoang, OD
A 36-year-old Caucasian male presented with a chief complaint of mild blur in the left eye at distance and near that improved to 20/20 with spectacle…

Genentech, Roche complete enrollment in phase 3 faricimab trials for wet AMD

December 16, 2019
Patient enrollment has been completed in two phase 3 trials of faricimab for wet age-related macular degeneration, according to communication from…

CHMP issues positive opinion for Beovu

December 13, 2019
Beovu has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency, Novartis announced in…

LHON patients see ‘dramatic, irreversible’ vision decline without treatment

December 12, 2019
A natural history study shows patients who have Leber’s hereditary optic neuropathy with the ND4 mutation have a dramatic and irreversible…

Eylea prefilled syringe now available

December 12, 2019
The Eylea injection prefilled syringe is now available to order, Regeneron Pharmaceuticals announced. The Eylea (aflibercept) 2 mg, single-dose…

First patient dosed in ProQR retinitis pigmentosa trial

December 12, 2019
ProQR Therapeutics has dosed the first patient in a phase 1/2 trial of QR-1123, its treatment candidate for autosomal dominant retinitis pigmentosa…

In the Journals

Nicotine reduces macular microcirculation

December 11, 2019
A decrease in macular microcirculation was detected after nicotine use, according to a study. Eighteen young, healthy, nonsmoking subjects and 18…

In the Journals

Ocriplasmin effective for resolution of vitreomacular traction

December 10, 2019
A phase 4 multicenter study found nearly half of patients with vitreomacular traction, with or without macular hole, who received an intravitreal…

From OSN Europe

GenSight’s LHON treatment receives French temporary authorization for use

December 10, 2019
A patient at France’s National Eye Hospital of the Quinze-Vingts has been granted temporary authorization for use of Lumevoq, GenSight…

Meeting NewsVideo

VIDEO: ERG can detect retinal ischemia

December 9, 2019
NEPTUNE, N.J. – ERG was shown to detect retinal ischemia before the presence of retinopathy, unveiling retinal function changes that may not be…

Study to focus on microgravity’s effect on microcirculation

December 6, 2019
A research study evaluating the effects microgravity has on the central microcirculation of the bodies of astronauts and jet pilots will begin in…

Foundation Fighting Blindness launches retinitis pigmentosa natural history study

December 5, 2019
A natural history study for people with retinitis pigmentosa caused by mutations in the gene EYS has been launched by the Foundation Fighting…

Benelux countries approve Iluvien for noninfectious posterior uveitis

December 4, 2019
Iluvien has been approved by the governmental agencies overseeing medical products in Belgium, the Netherlands and Luxemburg, Alimera Sciences…

Meeting NewsVideo

VIDEO: Oral eplerenone successfully treats central serous chorioretinopathy

December 4, 2019
NEPTUNE, N.J. – A 58-year-old man with distorted vision was diagnosed with central serous chorioretinopathy and was successfully treated with…